Remove 2027 Remove Healthcare Remove IT Remove Manufacturing
article thumbnail

Proposed LDT Rule Raises Many Questions but Provides Few Answers

FDA Law

The crux of the proposed rule lies in the addition of ten words: “ including when the manufacturer of these products is a laboratory.” These words would be added to the definition of “ in vitro diagnostic [IVD] products” in 21 C.F.R. Change to the IVD definition First, the mechanics of the change.

article thumbnail

“TAP Dancing” Towards Faster Device Commercialization: CDRH’s Total Product Life Cycle Advisory (“TAP”) Program

FDA Law

Shuren stated that some of the manufacturers of these devices have already experienced more interactions in the past few weeks than they otherwise would have over the entire development course of their devices. up to 225 total products enrolled through FY 2026 and up to 325 total products enrolled through FY 2027).